KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Baxter International (BAX) Asset Utilization Ratio (2009 - 2026)

Baxter International (BAX) reported Asset Utilization Ratio of 0.54 for Q1 2026, up 18.08% year-over-year from 0.46 in Q1 2025, and up 18.08% on a QoQ basis from 0.46 in Q1 2025.

Baxter International (BAX) has 18 years of Asset Utilization Ratio data on file, last reported at 0.54 in Q1 2026.

  • Quarterly Asset Utilization Ratio rose 18.08% year-over-year to 0.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.54 (up 18.08% YoY) and the FY2025 annual result came in at 0.49, up 24.68% from the prior year.
  • Asset Utilization Ratio improved to 0.54 in Q1 2026 per BAX's latest filing, from 0.46 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.54 in Q1 2026 and bottomed at 0.35 in Q4 2023.
  • The 5-year median for Asset Utilization Ratio is 0.41 (2022), against an average of 0.43.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio plunged 35.64%; it then climbed 23.21% in 2025.
  • Tracing BAX's Asset Utilization Ratio over 5 years: stood at 0.52 in 2022, then sank by 31.83% to 0.35 in 2023, then increased by 15.33% to 0.41 in 2024, then grew by 12.82% to 0.46 in 2025, then increased by 18.08% to 0.54 in 2026.
  • Per Business Quant, the three latest BAX Asset Utilization Ratio figures stand at 0.54 (Q1 2026), 0.46 (Q1 2025), and 0.41 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 0.26

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.54
Mar 31, 2025 0.46
Dec 31, 2024 0.41
Sep 30, 2024 0.40
Jun 30, 2024 0.39
Mar 31, 2024 0.37
Dec 31, 2023 0.35
Sep 30, 2023 0.39
Jun 30, 2023 0.44
Mar 31, 2023 0.47
Dec 31, 2022 0.52
Sep 30, 2022 0.46
Jun 30, 2022 0.41
Mar 31, 2022 0.39
Dec 31, 2021 0.46
Sep 30, 2021 0.63
Jun 30, 2021 0.62
Mar 31, 2021 0.60
Dec 31, 2020 0.58
Sep 30, 2020 0.58
Jun 30, 2020 0.59
Mar 31, 2020 0.62
Dec 31, 2019 0.64
Sep 30, 2019 0.64
Jun 30, 2019 0.66
Mar 31, 2019 0.69
Dec 31, 2018 0.68
Sep 30, 2018 0.66
Jun 30, 2018 0.66
Mar 31, 2018 0.63
Dec 31, 2017 0.61
Sep 30, 2017 0.60
Jun 30, 2017 0.63
Mar 31, 2017 0.66
Dec 31, 2016 0.65
Sep 30, 2016 0.64
Jun 30, 2016 0.60
Mar 31, 2016 0.52
Dec 31, 2015 0.48
Sep 30, 2015 0.40
Jun 30, 2015 0.38
Mar 31, 2015 0.42
Dec 31, 2014 0.41
Sep 30, 2014 0.48
Jun 30, 2014 0.52
Mar 31, 2014 0.56
Dec 31, 2013 0.59
Sep 30, 2013 0.59
Jun 30, 2013 0.64
Mar 31, 2013 0.70
Jun 30, 2012 0.75
Mar 31, 2012 0.74
Dec 31, 2011 0.75
Sep 30, 2011 0.78
Jun 30, 2011 0.77
Mar 31, 2011 0.76
Dec 31, 2010 0.73
Sep 30, 2010 0.75
Jun 30, 2010 0.76
Mar 31, 2010 0.73
Dec 31, 2009 0.73
Sep 30, 2009 0.75